Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease D Gomez-Almaguer, GJ Ruiz-Argüelles, L del Carmen Tarín-Arzaga, ... Biology of Blood and Marrow Transplantation 14 (1), 10-15, 2008 | 113 | 2008 |
Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults D Gómez-Almaguer, MA Herrera-Rojas, JC Jaime-Pérez, ... Blood, The Journal of the American Society of Hematology 123 (25), 3906-3908, 2014 | 104 | 2014 |
Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias D Gómez-Almaguer, M Solano-Genesta, L Tarín-Arzaga, ... Blood, The Journal of the American Society of Hematology 116 (23), 4783-4785, 2010 | 96 | 2010 |
Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience D Gómez-Almaguer, GJ Ruiz-Argüelles, L del Carmen Tarín-Arzaga, ... Biology of Blood and Marrow Transplantation 9 (3), 157-161, 2003 | 93 | 2003 |
Danazol as first-line therapy for aplastic anemia JC Jaime-Pérez, PR Colunga-Pedraza, CD Gómez-Ramírez, ... Annals of hematology 90 (5), 523-527, 2011 | 90 | 2011 |
High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia D Gómez‐Almaguer, L Tarín‐Arzaga, B Moreno‐Jaime, JC Jaime‐Pérez, ... European journal of haematology 90 (6), 494-500, 2013 | 76 | 2013 |
Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs? GJ Ruiz-Argüelles, LC Tarin-Arzaga, ML Gonzalez-Carrillo, ... Bone marrow transplantation 42 (1), 23-28, 2008 | 69 | 2008 |
Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine‐based conditioning regimen: the Mexican experience D Gómez‐Almaguer, J Vela‐Ojeda, JC Jaime‐Pérez, ... American journal of hematology 81 (3), 157-161, 2006 | 65 | 2006 |
Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial C Mancías-Guerra, AR Marroquín-Escamilla, O González-Llano, ... Cytotherapy 16 (6), 810-820, 2014 | 64 | 2014 |
Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico JC Jaime-Pérez, AC Heredia-Salazar, OG Cantú-Rodríguez, ... The Oncologist 20 (4), 386-392, 2015 | 63 | 2015 |
Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: A … GJ Ruiz-Argüelles, D Gómez-Almaguer, J David-Gomez-Rangel, ... Leukemia & lymphoma 45 (6), 1191-1195, 2004 | 63 | 2004 |
Síndrome de Hellp, diagnóstico y tratamiento CH Gutiérrez-Aguirre, J Alatorre-Ricardo, O Cantú-Rodríguez, ... Revista de Hematología 13 (4), 195-200, 2012 | 60 | 2012 |
Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia GJ Ruiz-Arguelles, D Gómez-Almaguer, B López-Martínez, ... Haematologica 87 (8), 894-896, 2002 | 58 | 2002 |
Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study CH Gutierrez-Aguirre, D Gomez-Almaguer, OG Cantu-Rodriguez, ... Bone marrow transplantation 40 (6), 535-539, 2007 | 45 | 2007 |
Outpatient allografting using non-myeloablative conditioning: the Mexican experience OG Cantú-Rodríguez, JC Jaime-Pérez, CH Gutiérrez-Aguirre, ... Bone marrow transplantation 40 (2), 119-123, 2007 | 45 | 2007 |
Higher doses of CD34+ progenitors are associated with improved overall survival without increasing GVHD in reduced intensity conditioning allogeneic transplant recipients with … D Gómez‐Almaguer, Á Gómez‐Peña, JC Jaime‐Pérez, ... Journal of Clinical Apheresis 28 (5), 349-355, 2013 | 43 | 2013 |
Constraints on the physical properties of GW190814 through simulations based on DECam follow-up observations by the dark energy survey R Morgan, M Soares-Santos, J Annis, K Herner, A Garcia, A Palmese, ... The Astrophysical Journal 901 (1), 83, 2020 | 42 | 2020 |
Long-term insulin independence in type 1 diabetes mellitus using a simplified autologous stem cell transplant OG Cantú-Rodríguez, F Lavalle-González, MÁ Herrera-Rojas, ... The Journal of Clinical Endocrinology & Metabolism 101 (5), 2141-2148, 2016 | 40 | 2016 |
Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant JC Jaime-Pérez, PR Colunga-Pedraza, B Gutiérrez-Gurrola, ... Blood Cells, Molecules, and Diseases 51 (1), 61-65, 2013 | 39 | 2013 |
No cytomegalovirus-related deaths after non-ablative stem cell allografts GJ Ruiz-Argüelles, D Gómez-Almaguer, B López-Martínez, ... Hematology 7 (2), 95-99, 2002 | 38 | 2002 |